Troy A. Ignelzi
Net Worth

Last updated:

What is Troy A. Ignelzi net worth?

The estimated net worth of Dr. Troy A. Ignelzi is at least $22,196,207 as of 22 Aug 2023. He has earned $19,213,457 from insider trading and has received compensation worth at least $2,982,750 in Karuna Therapeutics, Inc..

What is the salary of Troy A. Ignelzi?

Dr. Troy A. Ignelzi salary is $596,550 per year as Chief Financial Officer & Sec. in Karuna Therapeutics, Inc..

How old is Troy A. Ignelzi?

Dr. Troy A. Ignelzi is 57 years old, born in 1968.

What stocks does Troy A. Ignelzi currently own?

As insider, Dr. Troy A. Ignelzi owns shares in one company:

Company Title Shares Price per share Total value
Karuna Therapeutics, Inc. (KRTX) Chief Financial Officer & Sec. 30,487 $0 $0

What does Karuna Therapeutics, Inc. do?

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

KRTX logo
KRTX
Karuna Therapeutics, Inc.

Troy A. Ignelzi insider trading

Karuna Therapeutics, Inc.

Dr. Troy A. Ignelzi has made 47 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 855 units of KRTX stock worth $149,522 on 22 Aug 2023.

The largest trade he's ever made was exercising 16,500 units of KRTX stock on 9 Aug 2022. As of 22 Aug 2023 he still owns at least 30,487 units of KRTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 855 $174.88 $149,522
Sale
Common Stock 505 $175.59 $88,673
Sale
Common Stock 60 $176.6 $10,596
Sale
Common Stock 80 $173.64 $13,891
Option
Option (right to buy) 1,500 $9.2 $13,800
Option
Common Stock 1,500 $9.2 $13,800
Sale
Common Stock 782 $225.93 $176,677
Sale
Common Stock 724 $221.28 $160,207
Sale
Common Stock 2,093 $222.24 $465,148
Option
Option (right to buy) 9,000 $9.2 $82,800
Sale
Common Stock 3,309 $223.21 $738,602
Sale
Common Stock 1,070 $224.19 $239,883
Sale
Common Stock 1,022 $225.19 $230,144
Option
Common Stock 9,000 $9.2 $82,800
Option
Option (right to buy) 6,000 $9.2 $55,200
Option
Common Stock 6,000 $9.2 $55,200
Sale
Common Stock 6,000 $190.01 $1,140,060
Option
Common Stock 200 $9.2 $1,840
Option
Option (right to buy) 200 $9.2 $1,840
Sale
Common Stock 200 $200.14 $40,028
Sale
Common Stock 817 $201.41 $164,552
Option
Common Stock 817 $9.2 $7,516
Option
Option (right to buy) 817 $9.2 $7,516
Option
Common Stock 10,869 $9.2 $99,995
Option
Option (right to buy) 371 $9.2 $3,413
Option
Option (right to buy) 627 $9.2 $5,768
Option
Common Stock 627 $9.2 $5,768
Option
Common Stock 371 $9.2 $3,413
Option
Option (right to buy) 10,869 $9.2 $99,995
Option
Common Stock 16,500 $9.2 $151,800
Sale
Common Stock 16,500 $225.85 $3,726,525
Option
Option (right to buy) 16,500 $9.2 $151,800
Sale
Common Stock 400 $233.2 $93,280
Sale
Common Stock 1,100 $232 $255,200
Sale
Common Stock 2,000 $231.3 $462,600
Sale
Common Stock 1,000 $230.02 $230,020
Sale
Common Stock 2,459 $227.05 $558,316
Sale
Common Stock 33 $230.49 $7,606
Sale
Common Stock 5,189 $229.77 $1,192,277
Sale
Common Stock 2,819 $228.74 $644,818
Option
Common Stock 16,500 $9.2 $151,800
Sale
Common Stock 16,500 $227.83 $3,759,195
Option
Option (right to buy) 16,500 $9.2 $151,800
Option
Option (right to buy) 40 $9.2 $368
Option
Option (right to buy) 3,500 $9.2 $32,200
Sale
Common Stock 40 $134.46 $5,378
Option
Option (right to buy) 704 $9.2 $6,477
Option
Common Stock 40 $9.2 $368
Option
Common Stock 704 $9.2 $6,477
Sale
Common Stock 704 $133.2 $93,773
Option
Common Stock 3,500 $9.2 $32,200
Sale
Common Stock 3,500 $130.81 $457,835
Option
Option (right to buy) 1,500 $9.2 $13,800
Sale
Common Stock 1,500 $111.14 $166,710
Option
Common Stock 1,500 $9.2 $13,800
Option
Common Stock 6,970 $9.2 $64,124
Option
Option (right to buy) 6,970 $9.2 $64,124
Sale
Common Stock 13,500 $152.32 $2,056,320
Option
Common Stock 13,500 $9.2 $124,200
Option
Option (right to buy) 13,500 $9.2 $124,200
Option
Option (right to buy) 1,900 N/A N/A
Option
Common Stock 1,900 $9.2 $17,480
Sale
Common Stock 1,900 $120.05 $228,095
Option
Option (right to buy) 500 N/A N/A
Option
Common Stock 500 $9.2 $4,600
Sale
Common Stock 500 $120.05 $60,025
Option
Option (right to buy) 7,600 $4.6 $34,960
Option
Common Stock 7,600 $9.2 $69,920
Sale
Common Stock 7,000 $120.05 $840,350
Option
Option (right to buy) 5,000 $9.2 $46,000
Option
Common Stock 5,000 $9.2 $46,000
Option
Common Stock 2,600 $68.8 $178,880
Option
Option (right to buy) 2,600 $68.8 $178,880
Sale
Common Stock 2,248 $9.2 $20,682
Option
Option (right to buy) 900 $132.52 $119,268
Sale
Common Stock 900 $132.52 $119,268
Option
Common Stock 900 $132.52 $119,268
Option
Option (right to buy) 200 $120 $24,000
Option
Common Stock 200 $120 $24,000
Sale
Common Stock 200 $120 $24,000
Option
Option (right to buy) 7,000 $9.2 $64,400
Sale
Common Stock 7,000 $9.2 $64,400
Option
Common Stock 7,000 $9.2 $64,400
Option
Option (right to buy) 10,000 $9.2 $92,000
Option
Common Stock 10,000 $9.2 $92,000
Sale
Common Stock 10,000 $9.2 $92,000
Option
Common Stock 8,000 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Option (right to buy) 8,000 $9.2 $73,600
Option
Option (right to buy) 8,000 $9.2 $73,600
Option
Common Stock 8,000 $4.6 $36,800
Option
Option (right to buy) 8,000 $9.2 $73,600
Option
Common Stock 8,000 $4.6 $36,800
Option
Option (right to buy) 118 N/A N/A
Sale
Common Stock 118 N/A N/A
Option
Common Stock 118 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Common Stock 9,318 $106.64 $993,672
Option
Option (right to buy) 9,318 N/A N/A
Option
Common Stock 9,318 N/A N/A
Option
Option (right to buy) 564 N/A N/A
Sale
Common Stock 564 N/A N/A
Option
Common Stock 564 N/A N/A
Option
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Option
Option (right to buy) 2,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Option (right to buy) 5,000 N/A N/A
Sale
Common Stock 8,000 $54.6 $436,800
Option
Common Stock 8,000 $54.6 $436,800
Option
Common Stock 8,000 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Option (right to buy) 8,000 N/A N/A
Option
Option (right to buy) 8,000 $54.6 $436,800
Sale
Common Stock 2,000 N/A N/A
Option
Option (right to buy) 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Option (right to buy) 6,000 N/A N/A
Option
Option (right to buy) 6,000 $49.41 $296,460
Sale
Common Stock 2,000 N/A N/A
Option
Common Stock 6,000 $49.41 $296,460
Option
Common Stock 7,500 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Option
Option (right to buy) 7,500 N/A N/A
Option
Option (right to buy) 7,500 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Option
Common Stock 7,500 N/A N/A

Karuna Therapeutics key executives

Karuna Therapeutics, Inc. executives and other stock owners filed with the SEC: